Your search returned 31 studies. (Get alerts for new studies):
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Canandiaqua, New York
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Elmira, New York
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Elmira, New York
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Elmira, New York
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Canandiaqua, New York
- Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Conditions: Breast Cancer
Location: Canandiaqua, New York
- Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Breast Cancer - Cognitive/Functional Effects - Lung Cancer - Metastatic Cancer - Prostate Cancer
Location: Canandiaqua, New York
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Bellona, New York
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Canandaigua, New York
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Canandiaqua, New York
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Elmira, New York
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Canandiaqua, New York
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Elmira, New York
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Elmira, New York
- A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving
Conditions: Rheumatoid Arthritis
Location: Olean, New York
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Corning, New York
- A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Conditions: Cardiovascular Disease, Rheumatoid Arthritis
Location: Olean, New York
- An Open-Label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine+Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Ca
Conditions: Breast Cancer
Location: Canandaigua, New York
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Corning, New York
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Olean, New York
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Elmira, New York
- Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Elmira, New York
- Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome
Location: Elmira, New York
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Elmira, New York
- Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Canandiaqua, New York
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Canandiaqua, New York
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Canandiaqua, New York
- Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Conditions: Lung Cancer
Location: Canandiaqua, New York
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Cape
Conditions: Pancreatic Cancer
Location: Canandiaqua, New York
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Coudersport, Pennsylvania
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Coudersport, Pennsylvania
|